Minerva Neuroscie (NERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,948 | -12,418 | -31,523 | -31,685 | -20,425 |
| Depreciation Amortization | -38 | -26 | 32 | 97 | 91 |
| Income taxes - deferred | N/A | N/A | -9,376 | N/A | N/A |
| Accounts payable and accrued liabilities | -126 | 1,389 | -33 | 35 | -61 |
| Other Working Capital | -1,184 | -602 | 38,927 | 39,818 | 4,904 |
| Other Operating Activity | 4,138 | 725 | 5,066 | 3,740 | 2,602 |
| Operating Cash Flow | $-22,157 | $-10,932 | $3,093 | $12,005 | $-12,889 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 67,417 | 31,316 | -107,136 | -107,164 | -27,366 |
| PPE Investments | N/A | N/A | -52 | N/A | N/A |
| Investing Cash Flow | $67,417 | $31,316 | $-107,188 | $-107,164 | $-27,366 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,603 | -1,290 | -4,939 | -3,671 | -2,426 |
| Common Stock Issued | N/A | N/A | 55,050 | 55,050 | 9,933 |
| Other Financing Activity | 0 | 0 | -2,944 | -2,944 | -41 |
| Financing Cash Flow | $-2,603 | $-1,290 | $47,167 | $48,434 | $7,466 |
| Beginning Cash Position | 26,132 | 26,132 | 83,061 | 82,981 | 82,981 |
| End Cash Position | 68,789 | 45,226 | 26,132 | 36,255 | 50,191 |
| Net Cash Flow | $42,657 | $19,094 | $-56,929 | $-46,726 | $-32,789 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,157 | -10,932 | 3,093 | 12,005 | -12,889 |
| Capital Expenditure | N/A | N/A | -52 | N/A | N/A |
| Free Cash Flow | -22,157 | -10,932 | 3,041 | 12,005 | -12,889 |